Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study

Table 1 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) table for the SVPE safety and feasibility study

*For patients treated with SVPE. ‡ Assessed as per indication
^aWithin 14 days of onset of muscle weakness
^bNumber and duration of each SVPE session and volume of the plasma removed and the replacement fluid infused
^cBlood pressure, heart rate, body temperature, and pulse oximetry
^dHemoglobin (g/L), coagulation profile, serum level of calcium, magnesium, albumin, renal, and liver function test
^eComplete blood count, erythrocyte sedimentation rate (ESR), C-reactive protein, and microbiological investigations to assess CLABSI, CAUTI, and VAP
^fGBS disability score and MRC sum score

ISSN: 2055-5784